EUVIMEDEUVIMED entdecken
Übersichtsarbeit

An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship

Saghi Sepehri, Mina Khedmati

Archiv der Pharmazie · 03.07.2023

DOI: 10.1002/ardp.202300252 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 03.07.2023. Verfasst von Saghi Sepehri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. Hauptthemen laut MEDLINE: Urease, Enzyme Inhibitors, Heterocyclic Compounds. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Ardabil University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urease is a metalloenzyme including two Ni 2+ ions, found in some plants, bacteria, fungi, microorganisms, invertebrate animals, and animal tissues. Urease acts as a significant virulence factor, mainly in catheter blockage and infective urolithiasis as well as in the pathogenesis of gastric infection. Therefore, studies on urease lead to novel synthetic inhibitors. In this review, the synthesis and antiurease activities of a collection of privileged synthetic heterocycles such as (thio)barbiturate, (thio)urea, dihydropyrimidine, and triazol derivatives were described and discussed according to structure–activity relationship findings in search of the best moieties and substituents that are answerable for encouraging the desired activity even more potent than the standard. It was found that linking substituted phenyl and benzyl rings to the heterocycles led to potent urease inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UreaseEnzyme InhibitorsHeterocyclic CompoundsStructure-Activity RelationshipHumansAnimalsMolecular Structure

Stichwörter der Autor:innen

Helicobacter pyloricancertetrahydropyrimidinetriazoleurease

Substanzen

UreaseEnzyme InhibitorsHeterocyclic Compounds

Autor:innen und Institutionen

  • Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Students Research Committee, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.

Förderung

  • Ardabil University of Medical Sciences

Zitieren

APA

Sepehri, S., & Khedmati, M. (2023). An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300252

Vancouver

Sepehri S, Khedmati M. An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300252

BibTeX
@article{Sepehri2023,
  author = {Sepehri, Saghi and Khedmati, Mina},
  title = {An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202300252}
}
Kostenlos starten →